ClinicalTrials.Veeva

Menu

Lactobacillus Farciminis and Hyperalgesia

Lallemand logo

Lallemand

Status and phase

Completed
Phase 1

Conditions

Inflammation
Pain

Treatments

Drug: Placebo
Drug: Lactobacillus farciminis

Study type

Interventional

Funder types

Industry

Identifiers

NCT00852865
2008-A01380-55
HN 08-17

Details and patient eligibility

About

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Enrollment

48 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy volunteers

Exclusion criteria

  • consumption of yogurts

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

48 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
24 healthy volunteers consuming L.farciminis during three weeks
Treatment:
Drug: Lactobacillus farciminis
2
Placebo Comparator group
Description:
24 healthy volunteers consuming placebo during three weeks
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems